Literature DB >> 5687596

The excretion and metabolism of oral 14C-pyridostigmine in the rat.

M A Husain, J B Roberts, B H Thomas, A Wilson.   

Abstract

1. Pyridostigmine labelled with carbon-14 in the methyl group of the quaternary nitrogen has been used to investigate the excretion and metabolism of the drug after administration of single doses (500 mug) to the rat by stomach tube.2. Pyridostigmine is slowly excreted in the urine; the maximum excretion occurs between 1-3 hr after administration. In 24 hr 42% of the dose is excreted in urine and 38.4% is present in faeces and intestinal contents.3. The peak concentration of radioactivity in liver and blood occurs about 2 hr after administration.4. About 75% of the radioactivity in urine is present as unchanged pyridostigmine, the remainder as metabolite.5. The results are compared with those previously obtained after oral administration of neostigmine.6. It is concluded that after oral administration the absorption of pyridostigmine is greater and the metabolism substantially less than that of neostigmine.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5687596      PMCID: PMC1703348          DOI: 10.1111/j.1476-5381.1968.tb07064.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  An apparatus for the longterm collection of urine free from faecal and food contamination.

Authors:  R T BRITTAIN; P S SPENCER
Journal:  J Pharm Pharmacol       Date:  1963-07       Impact factor: 3.765

2.  Determination of neostigmine and pyridostigmine in the urine of patients with myasthenia gravis.

Authors:  P T NOWELL; C A SCOTT; A WILSON
Journal:  Br J Pharmacol Chemother       Date:  1962-06

3.  Excretion and metabolism of [14C]-pyridostigmine in the rat.

Authors:  R D Birtley; J B Roberts; B H Thomas; A Wilson
Journal:  Br J Pharmacol Chemother       Date:  1966-02

4.  Excretion and metabolism of oral 14-C neostigmine in the rat.

Authors:  J B Roberts; B H Thomas; A Wilson
Journal:  Biochem Pharmacol       Date:  1966-01       Impact factor: 5.858

5.  Metabolism of [14C]-neostigmine in the rat.

Authors:  J B Roberts; B H Thomas; A Wilson
Journal:  Br J Pharmacol Chemother       Date:  1965-12
  5 in total
  2 in total

1.  Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.

Authors:  K Yamamoto; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1996-08

2.  Placental transfer of pyridostigmine in the rat.

Authors:  J B Roberts; B H Thomas; A Wilson
Journal:  Br J Pharmacol       Date:  1970-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.